275 related articles for article (PubMed ID: 23188412)
21. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
Friis Wang N; Skouby SO; Humaidan P; Andersen CY
Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
[TBL] [Abstract][Full Text] [Related]
22. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
Levi-Setti PE; Cavagna M; Bulletti C
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
[TBL] [Abstract][Full Text] [Related]
23. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
Aydogan Mathyk B; Aslan Cetin B; Vardagli D; Zengin E; Sofiyeva N; Irez T; Ocal P
Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
[TBL] [Abstract][Full Text] [Related]
24. Altered vascular endothelial growth factor expression during GnRH antagonist protocol in women of reproductive age with normal baseline hormone profiles.
Koo YA; Lee B; Park HJ; Choi J; Lee E; Choi D
Fertil Steril; 2009 Mar; 91(3):744-8. PubMed ID: 18321491
[TBL] [Abstract][Full Text] [Related]
25. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
26. Serum and follicular endocrine profile is different in modified natural cycles than in cycles stimulated with gonadotropin and gonadotropin-releasing hormone antagonist.
Jancar N; Virant-Klun I; Bokal EV
Fertil Steril; 2009 Dec; 92(6):2069-71. PubMed ID: 19815198
[TBL] [Abstract][Full Text] [Related]
27. [Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].
Tsagareishvili GG
Georgian Med News; 2005 Feb; (119):18-23. PubMed ID: 15834173
[TBL] [Abstract][Full Text] [Related]
28. Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.
Zheng M; Tong J; Li WP; Chen ZJ; Zhang C
Gynecol Endocrinol; 2018 May; 34(5):446-450. PubMed ID: 29185361
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
Karnitis VJ; Townson DH; Friedman CI; Danforth DR
J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
[TBL] [Abstract][Full Text] [Related]
30. Follicular fluid contents of hyaluronic acid, follicle-stimulating hormone and steroids relative to the success of in vitro fertilization of human oocytes.
Suchanek E; Simunic V; Juretic D; Grizelj V
Fertil Steril; 1994 Aug; 62(2):347-52. PubMed ID: 8034084
[TBL] [Abstract][Full Text] [Related]
31. The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.
Albu D; Albu A
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850491
[TBL] [Abstract][Full Text] [Related]
32. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
33. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
34. Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles.
de los Santos MJ; García-Láez V; Beltrán-Torregrosa D; Horcajadas JA; Martínez-Conejero JA; Esteban FJ; Pellicer A; Labarta E
Hum Reprod; 2012 Jun; 27(6):1596-605. PubMed ID: 22451503
[TBL] [Abstract][Full Text] [Related]
35. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study.
Humaidan P; Bungum M; Bungum L; Yding Andersen C
Reprod Biomed Online; 2004 Jun; 8(6):635-43. PubMed ID: 15169576
[TBL] [Abstract][Full Text] [Related]
36. Sequential exposure of porcine cumulus cells to FSH and/or LH is critical for appropriate expression of steroidogenic and ovulation-related genes that impact oocyte maturation in vivo and in vitro.
Kawashima I; Okazaki T; Noma N; Nishibori M; Yamashita Y; Shimada M
Reproduction; 2008 Jul; 136(1):9-21. PubMed ID: 18456902
[TBL] [Abstract][Full Text] [Related]
37. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist.
Bo-Abbas YY; Martin KA; Liberman RF; Cramer DW; Barbieri RL
Fertil Steril; 2001 Apr; 75(4):694-9. PubMed ID: 11287021
[TBL] [Abstract][Full Text] [Related]
38. Cumulus and oocyte maturation and in vitro and in vivo fertilization of oocytes in relation to follicular steroids, prolactin, and glycosaminoglycans throughout the estrous period in superovulated heifers with a normal LH surge, no detectable LH surge, and progestin inhibition of LH surge.
Wise T; Suss U; Stranzinger G; Wuthrich K; Maurer RR
Domest Anim Endocrinol; 1994 Jan; 11(1):59-86. PubMed ID: 8124932
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study.
Franco JG; Baruffi RL; Oliveira JB; Mauri AL; Petersen CG; Contart P; Felipe V
Reprod Biol Endocrinol; 2009 Jun; 7():58. PubMed ID: 19497101
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
